ArticleFrontiers in oncology2025

Systemic therapy with pemigatinib and sintilimab followed by resection for recurrent FGFR-2-positive intrahepatic cholangiocarcinoma: a case report.

Yuchen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.